FLT3
FLT3-ITD and TKD mutations in AML. Targeted by midostaurin, gilteritinib, quizartinib.
No Clinical Trials found for this biomarker.
FLT3-ITD and TKD mutations in AML. Targeted by midostaurin, gilteritinib, quizartinib.
No Clinical Trials found for this biomarker.